A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction (clinicaltrials.gov) - Dec 9, 2025 - P2 | N=48 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P2 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
|